Warning: 3 New Downgrades That Could Hurt Your TFSA in April

These three downgraded stocks, including Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON), might be too dangerous for you to handle.

| More on:
Red siren flashing

Image source: Getty Images.

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Hello, Fools. I’m here again to highlight three stocks that have been recently downgraded by Bay Street. While we should never take analyst opinions as gospel, downgrades can often call our attention to hidden dangers — particularly in a TFSA account, where it’s easy to take risk for granted.

Without further ado, let’s get to it.

Chronic fatigue

Leading off our list is medical marijuana Cronos Group (TSX:CRON)(NASDAQ:CRON), which Canaccord Genuity downgraded to “sell” from “hold” this past Wednesday. Along with the downgrade, Cannacord analyst Matt Bottomley maintained his price target of $17, representing about 7% worth of downside from where it sits today.

Canaccord’s call comes in the wake of Cronos’s “fairly light” Q4 results. While Bottomley isn’t too worried about Cronos’s near-term results, he believes the valuation has gotten ahead of fundamentals.

“CRON currently trades at 91.7 times our 2020 EV/EBITDA, which is a significant premium to even the leading large-cap players in the space at 40 times with significantly higher recreational market shares and greater near-term revenue visibility versus Cronos,” Bottomley wrote.

Even with the recent pullback, Cronos shares are still up about 160% over the past year.

Bank shot

Next up we have Bank of Montreal (TSX:BMO)(NYSE:BMO), which Veritas Investment Research downgraded to “sell” on Wednesday. Along with the downgrade, Veritas analyst Nigel D’Souza lowered his price target to $95 (from $102), representing about 5% worth of downside from today’s prices.

D’Souza still likes BMO’s operations both in Canada and the U.S. as well as its potential for improved profitability but believes the valuation is now stretched considering looming industry risks. They include the possibility of an increase in credit losses, rising interest costs, and weak economic growth.

“Although we hold a favourable view of BMO’s underlying fundamentals, we note that its current valuation is above its historical premium relative to peers and expect shares to come under pressure as the sector multiple contracts over the coming quarters,” wrote D’Souza in a note to clients.

BMO shares are up about 13% in 2019.

All bought out

Rounding out our list is investment manager Gluskin Sheff + Associates (TSX:GS), which Desjardins Securities downgraded to “hold” from “buy” early last week.

The downgrade comes after Gluskin entered into a definitive agreement to be acquired by Onex for $14.25 per share, suggesting that the stock’s upside is pretty limited at this point. In fact, Desjardins analyst Gary Ho planted a price target of $14.25 on Gluskin to reflect the deal.

“We would recommend holding the stock given (1) the deal price at $14.25, (2) next quarterly dividend of 25 cents (to be declared in May), and (3) we would not rule out a possible competing bid,” said Ho.

Gluskin shares are up 38% so far in 2019.

The bottom line

There you have it, Fools: three recently downgraded stocks worth investigating further.

As always, don’t view these downgrades as formal recommendations to cut loose. Instead, use them as a starting point for further research. The track record of professionals is notoriously mixed, so your own due diligence is still required.

Fool on.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Brian Pacampara owns no position in any of the companies mentioned.   

More on Investing

A close up image of Canadian $20 Dollar bills
Dividend Stocks

3 Top Dividend Stocks to Buy Under $20

Given their stable cash flows and high dividend yields, these three under-$20 stocks could boost your passive income.

Read more »

Growing plant shoots on coins
Dividend Stocks

3 Dividend Stocks to Buy During Recession to Lock In a 6% Yield

Make the most of the recession with dividend investing. You can buy stocks for a discount and lock in higher…

Read more »

Bank sign on traditional europe building facade
Bank Stocks

Canadian Bank Stocks Near 52-Week Lows: Buy Them All With This ETF

Here's an easier way to buy the dip.

Read more »

Choice of fashion clothes of different colors on wooden hangers
Stocks for Beginners

Is Aritzia (TSX:ATZ) the Best TSX Stock to Buy in July 2022?

Aritzia’s international market expansion and improving profitability could help its stock recover fast.

Read more »

exchange traded funds

2 Cheap Vanguard and BlackRock ETFs to Buy and Hold Forever

These two funds are great ways to invest in the U.S. and Canadian stock markets.

Read more »

Dividend Stocks

Put TFSA Cash to Work: Earn a Tax-Free Yield of at Least 5%

By investing your TFSA cash in these stocks, you can earn a reliable and high yield of more than 5%.

Read more »

clock time

New TFSA Investors: Time to Buy Stocks Amid the Market Correction?

TD Bank (TSX:TD)(NYSE:TD) stock seems like a great long-term buy for beginner investors willing to put up with the short-term…

Read more »

young woman celebrating a victory while working with mobile phone in the office
Tech Stocks

3 Growth Stocks Trading at a Massive Discount Right Now

Canadian growth stocks such as Shopify have the potential to deliver market-beating gains to investors in the next year.

Read more »